Literature DB >> 29623355

Clinical and laboratory features of patients with osteomalacia initially presenting with neurological manifestations.

S W Kim1, N Hong2, Y Rhee2, Y-C Choi1, H Y Shin1, S M Kim3.   

Abstract

Patients with osteomalacia often visit the neurology department with conditions mimicking other myopathies. We analyzed clinical features of osteomalacia patients who visited the neurology department. These patients frequently presented with hypocalcemia, hypovitaminosis D, and pain with less severe weakness. Osteomalacia should be considered when patients present with pain and weakness.
INTRODUCTION: Osteomalacia is a disease of bone metabolism; however, some patients with osteomalacia initially visit the neurology department. As these patients often complain of weakness and gait disturbance, osteomalacia can be confused with other myopathies. We analyzed the clinical features of patients with osteomalacia who visited the neurology department.
METHODS: We retrospectively reviewed the medical records. Osteomalacia was diagnosed based on symptoms, laboratory features, and imaging results. We compared the characteristics of patients with osteomalacia who visited the neurology department with (1) those who did not visit the neurology department and (2) patients with idiopathic inflammatory myopathy.
RESULTS: Eighteen patients with osteomalacia visited the neurology department (NR group). The common etiologies in the NR group included tumors or antiepileptic medication, whereas antiviral medication was the most common in patients who did not visit the neurology department (non-NR group). The NR group showed lower serum calcium (p = 0.004) and 25-hydroxyvitamin D (p = 0.006) levels than the non-NR group. When compared with patients with inflammatory myopathy, both groups showed proximal dominant weakness. However, pain was more common in osteomalacia than in myopathy (p = 0.008), and patients with osteomalacia showed brisk deep tendon reflex more often (p = 0.017). Serum calcium (p = 0.003) and phosphate (p < 0.001) levels were lower in osteomalacia than in myopathy.
CONCLUSIONS: It was not uncommon for patients with osteomalacia to visit the neurology department. The clinical presentation of these patients can be more complex owing the superimposed neurological disease and accompanying hypocalcemia. Osteomalacia should be considered when patients present with pain and weakness.

Entities:  

Keywords:  Bone scan; Hypocalcemia; Hypophosphatemia; Osteomalacia

Mesh:

Year:  2018        PMID: 29623355     DOI: 10.1007/s00198-018-4501-1

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  36 in total

1.  The Association Between Antiepileptic Drugs and Bone Disease.

Authors:  Alison M. Pack
Journal:  Epilepsy Curr       Date:  2003-05       Impact factor: 7.500

2.  Muscular weakness in osteomalacia and hyperparathyroidism.

Authors:  R Smith; G Stern
Journal:  J Neurol Sci       Date:  1969 May-Jun       Impact factor: 3.181

3.  Practice patterns of neurologists regarding bone and mineral effects of antiepileptic drug therapy.

Authors:  C Valmadrid; C Voorhees; B Litt; C R Schneyer
Journal:  Arch Neurol       Date:  2001-09

4.  Elevated muscle enzymes in a patient with severe hypocalcemia mimicking polymyositis.

Authors:  D Hirata; T Nagashima; S Saito; H Okazaki; S Kano; S Minota
Journal:  Mod Rheumatol       Date:  2002-06       Impact factor: 3.023

5.  Hypophosphatemic osteomalacia induced by tenofovir in HIV-infected patients.

Authors:  Lourdes Mateo; Susana Holgado; Maria Luisa Mariñoso; Ricard Pérez-Andrés; Anna Bonjoch; Joan Romeu; Alejandro Olivé
Journal:  Clin Rheumatol       Date:  2014-05-03       Impact factor: 2.980

6.  Hypophosphataemic osteomalacia in patients on adefovir dipivoxil.

Authors:  Christian M Girgis; Tang Wong; Meng C Ngu; Louise Emmett; Katherine A Archer; Roger C Y Chen; Markus J Seibel
Journal:  J Clin Gastroenterol       Date:  2011 May-Jun       Impact factor: 3.062

7.  Loss of seizure control due to anticonvulsant-induced hypocalcemia.

Authors:  Fawzi Elhami Ali; Mahmoud A Al-Bustan; Waleed A Al-Busairi; Fatema A Al-Mulla
Journal:  Ann Pharmacother       Date:  2004-04-14       Impact factor: 3.154

8.  Noninvasive testing in the diagnosis of osteomalacia.

Authors:  C T Bingham; L A Fitzpatrick
Journal:  Am J Med       Date:  1993-11       Impact factor: 4.965

9.  Randomised controlled trial of methotrexate for chronic inflammatory demyelinating polyradiculoneuropathy (RMC trial): a pilot, multicentre study.

Authors: 
Journal:  Lancet Neurol       Date:  2009-01-10       Impact factor: 44.182

10.  Association between neurological and rheumatological manifestations in vitamin D deficiency and vitamin D levels.

Authors:  Faiza A Qari; Tariq A Nasser
Journal:  Pak J Med Sci       Date:  2013-05       Impact factor: 1.088

View more
  1 in total

1.  Osteomalacia and Vitamin D Status: A Clinical Update 2020.

Authors:  Salvatore Minisola; Luciano Colangelo; Jessica Pepe; Daniele Diacinti; Cristiana Cipriani; Sudhaker D Rao
Journal:  JBMR Plus       Date:  2020-12-21
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.